# Feasibility & Capacity Analysis: Human Squad vs. AI Swarm

## Executive Summary
This document provides a realistic "Reality Check" on what can be achieved in a 1-week (approx. 40-50 hour) competition window. It contrasts two distinct operational models:
1.  **The Human Squad**: 10 Engineers (400 Man-Hours).
2.  **The AI Swarm**: Autonomous Agent Ecosystem (500 Agent-Hours).

## 1. The Human Squad (10 Engineers / 400 Hours)

### Strengths & Weaknesses
*   **Strengths**: High-context decision making, navigating ambiguity, UI/UX polish, complex integration, ethical judgment.
*   **Weaknesses**: Fatigue, communication overhead (20-30% loss), slow context switching, manual boilerplate coding.

### Realistic Output (1 Week)
| Domain | Deliverable | Maturity Level |
|---|---|---|
| **Regulatory** | Hazard Analysis (Top 20 Risks), Draft 510(k) Skeleton, Intended Use Statement. | **Pre-Submission Draft** |
| **Frontend** | 5-7 Screen React/Next.js App. Clickable, partially wired to backend. High visual polish. | **Alpha Prototype** |
| **Backend** | Basic API (FastAPI/Node) with mock data + 2 real endpoints. | **Proof of Concept** |
| **AI/ML** | One standard model (e.g., U-Net) trained on a small subset of data. Evaluation metrics on one holdout set. | **Experimental** |
| **Tests** | Critical path unit tests only (coverage < 30%). | **Minimal** |

### Verdict
The Human Squad produces a **"Vertical Slice" Demo**. It looks good, works for the "Happy Path," but falls apart under edge cases. Excellent for pitching to investors or clinical stakeholders.

## 2. The AI Swarm (500 Agent-Hours)

*Assumption*: "500 Agent-Hours" implies a swarm of autonomous agents (e.g., AutoGPT, BabyAGI, or custom rigid agents) executing tasks in parallel or sequence, supervised by 1-2 humans.

### Strengths & Weaknesses
*   **Strengths**: Massive parallelism, instant boilerplate generation, exhaustive testing, parsing huge document sets (FDA guidance), generating variations.
*   **Weaknesses**: "Context Drift" (forgetting the goal), Hallucinations (dangerous in MedTech), Integration failure (components don't talk), lack of "taste" or UX cohesion.

### Realistic Output (1 Week)
| Domain | Deliverable | Maturity Level |
|---|---|---|
| **Regulatory** | 500-page "Regulatory Strategy" generated from 5,000 pages of FDA guidance. Auto-filled Templates. | **Volume-Heavy, Needs Review** |
| **Frontend** | 20 variations of a dashboard. Code is functional but potentially ugly or UX-deficient. | **Functional but Rough** |
| **Backend** | 50+ API endpoints generated with full Swagger docs. Database schema with 100 tables. | **Over-Engineered** |
| **AI/ML** | Hyperparameter sweep of 50 model architectures. Automated report on the best performer. | **Data-Rich** |
| **Tests** | 1,000+ generated unit tests (Coverage > 90%). | **High Reliability (Logic)** |

### Verdict
The AI Swarm produces a **"Foundation"**. It is ugly and disjointed but statistically robust. It handles the "boring" heavy lifting (docs, tests, boilerplate) but lacks the soul and usability of a human product.

## 3. The Hybrid "Centaur" Model (Recommended)

To win the MTCF, teams should adopt a Hybrid approach.

*   **Humans**: Define the Architecture, UI/UX, and Regulatory Strategy (The "Steering").
*   **AI**: Executes the Test Suites, generates the Boilerplate, parses the Regulatory Data, and runs the Hyperparameter Sweeps (The "Engine").

### Expected "Hybrid" Output (1 Week)
*   **Regulatory**: Human-validated strategy supported by AI-generated evidence.
*   **Product**: Polished UI (Human) connected to a robust, tested backend (AI).
*   **Status**: **"Beta Candidate"**. A working, tested, beautiful prototype that is functionally robust.
